Molecular events for promotion of vancomycin resistance in vancomycin intermediate Staphylococcus aureus
Vancomycin has been used as the last resort in the clinical treatment of serious Staphylococcus aureus infections. Vancomycin-intermediate S. aureus (VISA) was discovered almost two decades ago. Aside from the vancomycin-intermediate phenotype, VISA strains from the clinic or laboratory exhibited co...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2016-10-01
|
| シリーズ: | Frontiers in Microbiology |
| 主題: | |
| オンライン･アクセス: | http://journal.frontiersin.org/Journal/10.3389/fmicb.2016.01601/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|